Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):e88–e93. doi: 10.1097/QAI.0000000000000309

Figure 2.

Figure 2

The rationale for TB treatment initiation among participants with both AFB and Xpert results (A, N=124), AFB-positive results (B, N=56) AFB-negative results (C, N=68), Xpert-positive results (D, N=86), or Xpert-negative results (E, N=38).